Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06073171

Genomic Study of Cutis Tricolor

It's a study on Syndromic or Isolated Cutis Tricolor and had as main goal to identify the associated gene to the disease thanks to genetic analysis on minors patients and their parents reach by cutis Tricolor or not.

Recruiting

Interested in participating?

Request Info

Key information

Age range

4 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University, Montpellier

Montpellier, France

Location status: Recruiting

Location contact

Didier BESSIS

CONTACT

About this study

Cutis Tricolor (CT) is a rare cutaneous anomaly defined by pigmentary disorders associating large hyper- and hypopigmented macules of immediate proximity, selectively affecting the trunk. CT can be isolated, sporadic or integrated as a complex syndromic form such as Ruggieri-Happle syndrome (RHS) or various forms of pigmentovascular phacomatosis. A recent analysis of one case of RHS followed by CHU of Montpellier by whole exome sequencing allows the identification of a frameshift pathogen variant (heterozygous state) of a candidate gene.

The main objective is to confirm the association of the candidate gene with syndromic CT (SCT, Ruggierri-Happle syndrome) and non syndromic CT, from a genetic molecular blood and biopsy analysis of patients reach by CT and their parents presenting the disease or not. Furthermore, other objectives are to identify others associated candidates genes and to know better cutaneous pigmentary troubles factors, neurologics and eye abnormalities by identifying the differents cellulars pathways particularly the inflammatory pathway in the pathology of SCT.

First of all, it will have a pre-inclusion visit where Dr WILLEMS. M (Clinical Genetic Department - CHU Montpellier, France) and Pr BESSIS. D (Dermatology Department - CHU Montpellier, France) will explain the study's progress. Then, during the inclusion visit, families will sign inform consent for inclusion in the study. The same day, datas will be collected on demographic, clinical datas, including (i) a description of cutaneous, morphologic and extra-cutaneous anomalies and (ii) a cutaneous biopsy and (iii) a blood test will be done.

The genetics exams results will be return to patients during an usual follow-up visit, 12 months after their inclusion in the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Cutis Tricolor in trio (an affected parent, an unaffected parent) or in duo (one of the two affected parents)
  • Age : from 4 to 60 years

Exclusion criteria

  • Refusal to sign the informed consent
  • Patient who doesn't have a social security scheme or beneficiary of such a scheme
  • Pregnant or breastfeeding women
  • Patient whith a legal protection measure (guardianship, curatorship)
  • Patient under legal protection

Treatment and study plan

Blood sample

Biological

7.5 mL will be sampled on EDTA tube for each patient

Cutaneous biopsy

Biological

4 mm of damaged skin will be sampled after a premedication with lidocaine gel for 4 patients

High troughput sequencing of human's exome

Genetic

Sequencing on Illumina NovaSeq6000 platform, using the Twist Bioscience Human Core Exome kit + IntegraGen content, average 37Mb. This sequencing will be realised by external provider, IntegraGen society.

Primary outcomes

  1. Number of patients in whom a pathogenic or probably pathogenic variant has been identified by exome sequencing

    Time frame: 12 months

Secondary outcomes

  1. Number of patients in whom a pathogenic or probably pathogenic variant in the same gene as another patient in the series has been identified

    Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Didier BESSIS, Prof.

CONTACT

[email protected]

04 67 33 69 06

Marjolaine WILLEMS, Dr

CONTACT

[email protected]

04 67 33 65 64

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Collaborators

  • IntegraGen SA

Registry information

Acronym: Cutis Tricolor

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Oct 10, 2023
Registry last updated
Oct 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.